GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice

Neurobiology of Disease

Volumn 20, Issue 3, 2005, Pages 890-897

  Van Looij, M A J ^a   Van Der Burg, H ^a   Van Der Giessen, R S ^a   De Ruiter, M M ^a   Van Der Wees, J ^a   Van Doorninck, J H ^a   De Zeeuw, C I ^a   Van Zanten, G A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

DPOAE; EM; GATA3; HDR syndrome; Hearing loss; OHC; Vacuole

Indexed keywords

TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ARTICLE; CELL VACUOLE; DISTORTION PRODUCT OTOACOUSTIC EMISSION; HAIR CELL; HEARING IMPAIRMENT; HEARING LOSS; HETEROZYGOTE; HUMAN; HYPOPARATHYROIDISM; KIDNEY DYSPLASIA; KNOCKOUT MOUSE; MICROSCOPY; MOUSE; NOISE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

AGE FACTORS; ANIMALS; COCHLEAR MICROPHONIC POTENTIALS; COCHLEAR NERVE; CYTOPLASM; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENOTYPE; HAIR CELLS, OUTER; HEARING LOSS, SENSORINEURAL; HYPOPARATHYROIDISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MULTICYSTIC DYSPLASTIC KIDNEY; SPIRAL GANGLION; SYNAPTIC TRANSMISSION; VACUOLES;

EID: 27744434077     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.05.025     Document Type: Article

References (41)

1. R.W. Bilous, G. Murty, D.B. Parkinson, R.V. Thakker, M.G. Coulthard, J. Burn, D. Mathias, and P. Kendall-Taylor Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia N. Engl. J. Med. 327 1992 1069 1074
2. B.A. Bohne, and G.W. Harding Processing and analyzing the mouse temporal bone to identify gross, cellular and subcellular pathology Hear. Res. 109 1997 34 45
3. J.J. Brown, R.E. Brummett, M.B. Meikle, and J. Vernon Combined effects of noise and neomycin Acta Oto-Laryngol. 86 1978 394 400
4. C. Debacker, M. Catala, and M.C. Labastie Embryonic expression of the human GATA-3 gene Mech. Dev. 85 1999 183 187
5. S. Fujimoto, K. Yokochi, H. Morikawa, M. Nakano, H. Shibata, H. Togari, and Y. Wada Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome Am. J. Med. Genet. 86 1999 427 429
6. R.P. Hamernik, J.H. Patterson, G.A. Turrentine, and W.A. Ahroon The quantitative relation between sensory cell loss and hearing thresholds Hear. Res. 38 3 1989 199 211
7. T. Hasegawa, Y. Hasegawa, T. Aso, S. Koto, T. Nagai, Y. Tsuchiya, K.C. Kim, H. Ohashi, K. Wakui, and Y. Fukushima HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13) Am. J. Med. Genet. 73 1997 416 418
8. J.M. Huang, M.K. Money, C.I. Berlin, and B.J. Keats Auditory phenotyping of heterozygous sound-responsive (+/dn) and deafness (dn/dn) mice Hear. Res. 88 1995 61 64
9. J.M. Huang, C.I. Berlin, S.T. Lin, and B.J. Keats Low intensities and 1.3 ratio produce distortion product otoacoustic emissions which are larger in heterozygous (+/dn) than homozygous (+/+) mice Hear. Res. 117 1998 24 30
10. A.M. Jimenez, B.B. Stagner, G.K. Martin, and B.L. Lonsbury-Martin Age-related loss of distortion product otoacoustic emissions in four mouse strains Hear. Res. 138 1999 91 105
11. A.M. Jimenez, B.B. Stagner, G.K. Martin, and B.L. Lonsbury-Martin Susceptibility of DPOAEs to sound overexposure in inbred mice with AHL J. Assoc. Res. Otolaryngol. 2 2001 233 245
12. A. Kakigi, H. Hirakawa, N. Harel, R.J. Mount, and R.V. Harrison Comparison of distortion-product and transient evoked otoacoustic emissions with ABR threshold shift in chinchillas with ototoxic damage Auris, Nasus, Larynx 25 1998 223 232
13. A. Karis, I. Pata, J.H. van Doorninck, F. Grosveld, C.I. de Zeeuw, D. de Caprona, and B. Fritzsch Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear J. Comp. Neurol. 429 2001 615 630
14. D. Konrad-Martin, S.J. Norton, K.E. Mascher, and B.L. Tempel Effects of PMCA2 mutation on DPOAE amplitudes and latencies in deafwaddler mice Hear. Res. 151 2001 205 220
15. G. Lawoko-Kerali, M.N. Rivolta, and M. Holley Expression of the transcription factors GATA3 and Pax2 during development of the mammalian inner ear J. Comp. Neurol. 442 2002 378 391
16. S. Le Calvez, P. Avan, L. Gilain, and R. Romand CD1 hearing-impaired mice: I. Distortion product otoacoustic emission levels, cochlear function and morphology Hear. Res. 120 1998 37 50
17. S. Le Calvez, A. Guilhaume, R. Romand, J.M. Aran, and P. Avan CD1 hearing-impaired mice: II. Group latencies and optimal f2/f1 ratios of distortion product otoacoustic emissions, and scanning electron microscopy Hear. Res. 120 1998 51 61
18. D. Li, C.M. Henley, and B.W. O'Malley Jr. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse Hear. Res. 138 1999 65 72
19. P. Lichtner, R. Konig, T. Hasegawa, H. Van Esch, T. Meitinger, and S. Schuffenhauer An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14 J. Med. Genet. 37 2000 33 37
20. K.C. Lim, G. Lakshmanan, S.E. Crawford, Y. Gu, F. Grosveld, and J.D. Engel Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system Nat. Genet. 25 2000 209 212
21. K. Muroya, T. Hasegawa, Y. Ito, T. Nagai, H. Isotani, Y. Iwata, K. Yamamoto, S. Fujimoto, S. Seishu, Y. Fukushima, Y. Hasegawa, and T. Ogata GATA3 abnormalities and the phenotypic spectrum of HDR syndrome J. Med. Genet. 38 2001 374 380
22. Oei, M.L.Y.M. Segenhout, M. Dijk, F. Albers. F.W.J., 2003. Ultrastructural morphology of the guinea pig ear after systemic gentamycin application. "Morphology and electrophysiology of the vestibular organ in the guinea pig," Thesis University of Groningen. pp. 57-70.
23. H.C. Ou, G.W. Harding, and B.A. Bohne An anatomically based frequency place map for the mouse cochlea Hear. Res. 3460 2000 1 7
24. P.P. Pandolfi, M.E. Roth, A. Karis, M.W. Leonard, E. Dzierzak, F.G. Grosveld, J.D. Engel, and M.H. Lindenbaum Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis Nat. Genet. 11 1995 40 44
25. K. Parham Distortion product otoacoustic emissions in the C57BL/6J mouse model of age-related hearing loss Hear. Res. 112 1997 216 234
26. K. Parham, X.M. Sun, and D.O. Kim Distortion product otoacoustic emissions in the CBA/J mouse model of presbycusis Hear. Res. 134 1999 29 38
27. I. Pata, M. Studer, J.H. van Doorninck, J. Briscoe, S. Kuuse, J.D. Engel, F. Grosveld, and A. Karis The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4 Development 126 1999 5523 5531
28. M.N. Rivolta, and M.C. Holley GATA3 is downregulated during hair cell differentiation in the mouse cochlea J. Neurocytol. 27 1998 637 647
29. A. Schrott, K. Stephan, and H. Spoendlin Auditory brainstem response thresholds in a mouse mutant with selective outer hair cell loss Eur. Arch. Otolaryngol. 247 1990 8 11
30. A. Schrott, J.L. Puel, and G. Rebillard Cochlear origin of 2f1-f2 distortion products assessed by using 2 types of mutant mice Hear. Res. 52 1991 245 253
31. X.M. Sun, and D.O. Kim Adaptation of 2f1-2f2 distortion product otoacoustic emission in young-adult and old CBA and C57 mice J. Acoust. Soc. Am. 105 6 1999 3399 3409
32. C.N. Ting, M.C. Olson, K.P. Barton, and J.M. Leiden Transcription factor GATA-3 is required for development of the T-cell lineage Nature 384 1996 474 478
33. J. van der Wees, M.A.J. van Looij, M.M. de Ruiter, H. Elias, H. van der Burg, S.S. Liem, D. Kurek, J.D. Engel, A. Karis, G.A. van Zanten, C.I. de Zeeuw, F.G. Grosveld, and J.H. van Doorninck Hearing loss following GATA3 haploinsufficiency is caused by cochlear disorder Neurobiol. Dis. 16 2004 169 178
34. J.H. van Doorninck, J. van der Wees, A. Karis, E. Goedknegt, J.D. Engel, M. Coesmans, M. Rutteman, F. Grosveld, and C.I. De Zeeuw GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei J. Neurosci. 19 1999 RC12
35. H. van Esch, and R.W. Bilous GATA3 and kidney development: why case reports are still important Nephrol., Dial., Transplant 16 2001 2130 2132
36. H. van Esch, and K. Devriendt Transcription factor GATA3 and the human HDR syndrome Cell. Mol. Life Sci. 58 2001 1296 1300
37. H. van Esch, P. Groenen, M.A. Nesbit, S. Schuffenhauer, P. Lichtner, G. Vanderlinden, B. Harding, R. Beetz, R.W. Bilous, I. Holdaway, N.J. Shaw, J.P. Fryns, W. Van de Ven, R.V. Thakker, and K. Devriendt GATA3 haplo-insufficiency causes human HDR syndrome Nature 406 2000 419 422
38. A.E. Vazquez, A.E. Luebke, G.K. Martin, and B.L. Lonsbury-Martin Temporary and permanent noise-induced changes in distortion product otoacoustic emissions in CBA/CaJ mice Hear. Res. 156 2001 31 43
39. D.E. Vetter, J.R. Mann, P. Wangemann, J. Liu, K.J. McLaughlin, F. Lesage, D.C. Marcus, M. Lazdunski, S.F. Heinemann, and J. Barhanin Inner ear defects induced by null mutation of the isk gene Neuron 17 1996 1251 1264
40. N.K. Woolf, A.F. Ryan, and R.C. Bone Neural phase-locking properties in the absence of cochlear outer hair cells Hear. Res. 4 1981 335 346
41. W. Zheng, and R.A. Flavell The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells Cell 89 1997 587 596